Latest statistics and disclosures from Aquilo Capital Management's latest quarterly 13F-HR filing:
- Top 5 stock holdings are XBI, DRNA, ANAB, QURE, SPRO, and represent 71.24% of Aquilo Capital Management's stock portfolio.
- Added to shares of these 10 stocks: XBI (+$112M), BPMC (+$25M), RGNX (+$10M), ARGX (+$8.1M), QURE (+$8.0M), DRNA (+$5.5M), ARWR (+$5.5M), ANAB, SPRO, NGM.
- Started 2 new stock positions in BPMC, ARGX.
- Reduced shares in these 2 stocks: XENE (-$17M), MRUS (-$9.3M).
- Sold out of its positions in XENE, MRUS.
- Aquilo Capital Management was a net buyer of stock by $154M.
- Aquilo Capital Management has $496M in assets under management (AUM), growing by 93.28%.
Portfolio Holdings for Aquilo Capital Management
Companies in the Aquilo Capital Management portfolio as of the June 2020 quarterly 13F filing
|Company (Ticker)||Portfolio Weight||Valued At||Change in Shares||Share Count||Share Price|
|Spdr Ser Tr S&p Biotech Unit Put Option (XBI)||45.1||$224M||+100%||2.0M||111.95|
|Dicerna Pharmaceuticals (DRNA)||7.5||$37M||+17%||1.5M||25.40|
|Anaptysbio Inc Common (ANAB)||7.2||$36M||+10%||1.6M||22.34|
|Uniqure Nv SHS (QURE)||6.2||$31M||+35%||680k||45.06|
|Spero Therapeutics (SPRO)||5.3||$26M||+6%||1.9M||13.53|
|Blueprint Medicines (BPMC)||5.0||$25M||NEW||315k||78.00|
|Arrowhead Pharmaceuticals (ARWR)||4.9||$24M||+29%||563k||43.19|
|Ngm Biopharmaceuticals (NGM)||4.4||$22M||+4%||1.1M||19.74|
|Regenxbio Inc equity us cm (RGNX)||4.1||$20M||+102%||554k||36.83|
|Pieris Pharmaceuticals (PIRS)||3.5||$17M||5.6M||3.10|
|Proqr Thrapeutics N V Shs Euro (PRQR)||2.9||$15M||2.4M||6.08|
|Galapagos Nv Spon Adr (GLPG)||1.8||$8.7M||44k||197.29|
|Argenx Se Sponsored Adr (ARGX)||1.6||$8.1M||NEW||36k||225.22|
|Morphosys Sponsored Ads (MOR)||0.6||$3.0M||96k||31.67|
Past Filings by Aquilo Capital Management
SEC 13F filings are viewable for Aquilo Capital Management going back to 2018
- Aquilo Capital Management 2020 Q1 filed May 15, 2020
- Aquilo Capital Management 2019 Q4 filed Feb. 14, 2020
- Aquilo Capital Management 2019 Q3 filed Nov. 14, 2019
- Aquilo Capital Management 2019 Q2 filed Aug. 14, 2019
- Aquilo Capital Management 2019 Q1 filed May 15, 2019
- Aquilo Capital Management 2018 Q4 filed Feb. 14, 2019